104 related articles for article (PubMed ID: 33105501)
1. Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US.
Vigneswaran HT; Schwarzman LS; Madueke IC; David SM; Nordenstam J; Moreira D; Abern MR
Ann Surg Oncol; 2021 May; 28(5):2790-2800. PubMed ID: 33105501
[TBL] [Abstract][Full Text] [Related]
2. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
[TBL] [Abstract][Full Text] [Related]
3. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
[TBL] [Abstract][Full Text] [Related]
4. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
5. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
6. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
7. Adverse postoperative outcomes associated with perioperative blood transfusion in gynecologic oncology surgery.
Swift BE; Maeda A; Bouchard-Fortier G
Int J Gynecol Cancer; 2023 Apr; 33(4):585-591. PubMed ID: 36792167
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
[TBL] [Abstract][Full Text] [Related]
9. Perioperative outcomes in male patients undergoing cystectomy, radical colorectal procedure or total pelvic exenteration.
Naha U; Khurshudyan A; Vigneswaran HT; Mima M; Abern MR; Moreira DM
Transl Androl Urol; 2023 Nov; 12(11):1631-1637. PubMed ID: 38106684
[TBL] [Abstract][Full Text] [Related]
10. A single-institution approach to total pelvic exenteration.
Chokshi RJ; Fowler J; Cohn D; Bahnson R; Lumbley J; Martin EW
Am Surg; 2011 Dec; 77(12):1629-39. PubMed ID: 22273221
[TBL] [Abstract][Full Text] [Related]
11. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
Katory M; McLean R; Paez E; Kucukmetin A; Naik R
Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
[TBL] [Abstract][Full Text] [Related]
13. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
[TBL] [Abstract][Full Text] [Related]
14. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality.
Goldberg JM; Piver MS; Hempling RE; Aiduk C; Blumenson L; Recio FO
Ann Surg Oncol; 1998; 5(5):399-406. PubMed ID: 9718168
[TBL] [Abstract][Full Text] [Related]
15. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
[TBL] [Abstract][Full Text] [Related]
16. Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database.
Prescott LS; Aloia TA; Brown AJ; Taylor JS; Munsell MF; Sun CC; Schmeler KM; Levenback CF; Bodurka DC
Gynecol Oncol; 2015 Jan; 136(1):65-70. PubMed ID: 25451693
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenterations for gynecologic cancers: A retrospective analysis of a 30-year experience in a cancer center.
Knight S; Lambaudie E; Sabiani L; Mokart D; Provansal M; Tallet A; Houvenaeghel G
Eur J Surg Oncol; 2018 Dec; 44(12):1929-1934. PubMed ID: 30262326
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting hospital length of stay following pelvic exenteration surgery.
Guo Y; Chang E; Bozkurt M; Park M; Liu D; Fu JB
J Surg Oncol; 2018 Mar; 117(3):529-534. PubMed ID: 29044540
[TBL] [Abstract][Full Text] [Related]
19. Palliative Total Pelvic Exenteration for Gynecologic Cancers: A Cross-sectional Study of Society of Gynecologic Oncology Members.
MacLaughlan David S; Marjon N; English D; Purington N; Han SS; Dizon DS
Int J Gynecol Cancer; 2018 Nov; 28(9):1796-1804. PubMed ID: 30371565
[TBL] [Abstract][Full Text] [Related]
20. Longer Operative Time During Benign Laparoscopic and Robotic Hysterectomy Is Associated With Increased 30-Day Perioperative Complications.
Catanzarite T; Saha S; Pilecki MA; Kim JY; Milad MP
J Minim Invasive Gynecol; 2015; 22(6):1049-58. PubMed ID: 26070725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
